Atara Biotherapeutics Announces Pricing of $150.0 Million Public Offering GlobeNewswire
SOUTH SAN FRANCISCO, Calif., July 18, 2019 (GLOBE NEWSWIRE) — Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell …
Atara Biotherapeutics Announces Pricing of $150.0 Million Public Offering GlobeNewswire
SOUTH SAN FRANCISCO, Calif., July 18, 2019 (GLOBE NEWSWIRE) — Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell …